RegMed Forum “The multifaceted potential of CRISPR-Cas9 in medicine”

Preliminary agenda

Moderator: Dimitrios Wagner, BCRT/BeCAT

16.15                    Registration & Coffee                              

17.00-17.05       Jasmin Podufall (BPWT) - Welcome Address

17.05-17.15        Dimitrios Wagner (BCRT/BeCAT) - Evolution of the CRISPR-Cas9 technology

17.15-17.35        N.N. (University of Regensburg) - CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia (title tbc)

17.35-17.55        Leila Amini (BCRT/BeCAT) - CRISPR-based immune cell therapies (title tbc)

17.55-18.15        Andre Cohnen (Bayer AG) - Novel CRISPR enzymes from nature and lab (title tbc)

18.15-19.00        BREAK                            

19.00-19.20        Michael Kaminski (MDC/Charité) - CRISPR-based diagnostics (title tbc)

19.20-19.40        Simone Spuler (MDC/Charité) - CRISPR-based therapies for genetic muscle disorders (title tbc)

19.40-20.10        N.N.               

20.10-20.20        Dimitrios Wagner  & Jasmin Podufall - Closing remarks

20.20-21.15        Get together & Networking

Organisator*innen